Sun Pharma Q2 net falls 46.5% on Protonix provision

Sun Pharmaceutical Industries reported a 46.5 percent drop in quarterly net profit after it set aside Rs 5.84 billion towards a possible compensation in a patent dispute case related to drug Protonix.

The Mumbai-based drugmaker said consolidated net profit fell to Rs 3.2 billion during fiscal second quarter ended September from Rs 5.98 billion a year earlier. Net sales rose 40.2 percent to Rs 26.57 billion.

Analysts had estimated the net profit at Rs 7.68 billion, according to Thomson Reuters I/B/E/S.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Lawmakers must not dilute penalties for insurers on mis-selling

    The much delayed insurance laws (amendment) bill is back in the news and the positive statements of finance minister Arun Jaitley suggest that the gov

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Arun Nigavekar

New model for effective education

After interacting with students and teaching community on a ...

Zehra Naqvi

Being unrealistic can be good for you

Depression is a term that most people use very casually ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture